US 12,133,907 B2
Lipophilic third generation retinoid
Daniel Winn, Kingston, NJ (US)
Assigned to Actera Ingredients, Inc., Newtown, PA (US)
Filed by Actera Ingredients, Inc., Newtown, PA (US)
Filed on Jan. 7, 2022, as Appl. No. 17/570,851.
Claims priority of provisional application 63/134,772, filed on Jan. 7, 2021.
Prior Publication US 2022/0211597 A1, Jul. 7, 2022
Int. Cl. A61K 8/37 (2006.01); A61K 8/31 (2006.01); A61Q 19/08 (2006.01); C07C 69/76 (2006.01)
CPC A61K 8/37 (2013.01) [A61K 8/31 (2013.01); A61Q 19/08 (2013.01); C07C 69/76 (2013.01); A61K 2800/30 (2013.01)] 20 Claims
 
1. A compound of Formula I:

OG Complex Work Unit Chemistry
wherein R1 is unsubstituted, saturated or unsaturated, linear or branched, aliphatic hydrocarbyl having six to twenty-two carbon atoms.